Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
about
Current concepts and future directions in the pathogenesis and treatment of non-infectious intraocular inflammation.Alemtuzumab therapy for multiple sclerosis.Immunomodulation of autoimmune responses with monoclonal antibodies and immunoadhesins: treatment of ocular inflammatory disease in the next millennium.Pharmacotherapy for uveitis: current management and emerging therapy.From bench to bedside: discovering rules for antibody design, and improving serotherapy with monoclonal antibodies.Diagnostic techniques for inflammatory eye disease: past, present and future: a review.A review of Campath in autoimmune disease: biologic therapy in the gray zone between immunosuppression and immunoablation.Alemtuzumab: evidence for its potential in relapsing-remitting multiple sclerosis.Pharmacotherapy of scleritis: current paradigms and future directions.Update on the use of systemic biologic agents in the treatment of noninfectious uveitis.A review and update on orphan drugs for the treatment of noninfectious uveitisEmerging biologics in the treatment of uveitis.The role of biologic agents in the management of non-infectious uveitis.Short term immunosuppressive therapy and long-term immunoregulation: promises and problems.Nasal administration of retinal antigens maintains immunosuppression of uveoretinitis in cyclosporin-A-treated Lewis rats: future treatment of endogenous posterior uveoretinitis?Campath-1H therapy in refractory ocular inflammatory disease.Penetration of engineered antibody fragments into the eye.Alemtuzumab-induced remission of multiple sclerosis-associated uveitis.
P2860
Q27693189-07275146-54D4-4BC2-9449-511A0A2CB9AFQ33404568-48A40DA4-6720-4CB9-A5CD-68F70B760D42Q33760317-0E472C97-7342-44D4-8B3F-B7E0E6C3C2AFQ34274075-14F27261-D577-4768-B5B9-F06D42345CD1Q34321820-6DBE7CAF-1EA9-4BE6-BB65-80409C46CC55Q34910419-C14E3B45-1323-454D-AD4A-2CD398FDCDF6Q36194538-B99E7DCB-CAFB-44B4-9FF3-8A629C4AB91DQ36672726-A6A0AD10-45B3-4457-8A12-97D93613A7A3Q37466204-76F7EDF1-4A3E-4FB0-838F-3D562FA04F6AQ37600483-2C031D78-E7EC-4F52-8B7C-F4D21CFEB149Q37632096-CB16B90B-C9AA-472D-BAE3-BC09D652322BQ37754665-A30B89CA-BBC6-4935-BB39-8CE38EA3A097Q38025152-A590CF77-FBC6-40CF-BB6A-BB6371274EDEQ39723711-43C3E3EB-D0D9-4CEB-890B-8E98A1B506B0Q40909960-092A84C9-ECFD-420C-A365-69766F3AC94EQ42186381-9452C7C3-28C5-47F4-AFF7-2BEC15A10AC6Q43975336-1400E0DD-E71A-4E89-A595-55D6C62E355AQ47983705-20083B5F-E226-45F6-9D38-6F451EEAE00A
P2860
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@en
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@nl
type
label
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@en
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@nl
prefLabel
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@en
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H.
@nl
P2093
P2860
P356
P1476
Monoclonal antibody therapy of chronic intraocular inflammation using Campath-1H
@en
P2093
P2860
P304
P356
10.1136/BJO.79.11.1054
P407
P577
1995-11-01T00:00:00Z